Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
NCT ID:
NCT02424669
Eligibility Criteria:
Inclusion Criteria:
Group 1 and Group 2:
* with sporadic ALS (without family history), recently diagnosed (onset of first symptoms \< 24 months) group 1, not recently diagnosed (onset of first symptoms \> 24 months) group 2
* Who meet the laboratory-supported probable, probable or definite form of ALS according to the El Escorial criteria
* Suffering from the spinal form of ALS
Group 3:
\- with an inflammatory peripheral neuropathy, or a non inflammatory peripheral neuropathy, recently diagnosed
Exclusion Criteria:
* Familial form of ALS
* Bulbar form and respiratory onset form of ALS
* Subjects with a clinically significant history of unstable or severe cardiac, oncologic, hepatic or renal disease, or other medically significant illness.
* Subjects with significant cognitive impairment, clinical dementia, or psychiatric illness.
* Female of childbearing potential (apart of patient using adequate contraceptive measures), pregnant or breast feeding
* Suspected inability to complete the study follow-up (foreign workers, transient visitors, tourists or any others for whom follow-up evaluation is not assured)
* Participation in any other clinical study within 30 days prior to the Screening Visit
* Persons deprived of freedom by judicial or administrative decision, hospitalized without their consent or for other reasons than the research, under legal protection or unable to express their consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02424669
Study Brief:
Protocol Section:
NCT02424669